Company Guardant Health, Inc.

Equities

GH

US40131M1099

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 10:22:06 2026-03-16 am EDT			5-day change	1st Jan Change
87.36 ^USD	+2.19%		-3.29%	-13.65%

Mar. 11	Guardant Health, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 01:00 PM
Mar. 11	Braidwell, Karnal and Kreiter's AI healthcare fund, surged 28% last year	RE

Business description: Guardant Health, Inc.

Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. It offers other tests, including Guardant360 TissueNext tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.

Number of employees: 2,498

Sales by Activity: Guardant Health, Inc.

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Medical Labs & Research	374M	450M	564M	739M	982M

See all business segments

Geographical breakdown of sales: Guardant Health, Inc.

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
United States	353M	421M	527M	697M	923M
International	21.09M	28.92M	37.42M	41.85M	58.74M

See all geographic segments

Executive Committee: Guardant Health, Inc.

Manager	Title	Age	Since
Helmy Eltoukhy CEO	Chief Executive Officer	47	2012-12-31
AmirAli Talasaz CEO	Chief Executive Officer	46	2021-08-04
Michael Bell DFI	Director of Finance/CFO	57	2021-01-04
Andrew Ament COO	Chief Operating Officer	-	-
Darya Chudova CTO	Chief Tech/Sci/R&D Officer	52	2015-07-31

See GUARDANT HEALTH, INC. governance

Composition of the Board of Directors: Guardant Health, Inc.

Director	Title	Age	Since
Helmy Eltoukhy CHM	Chairman	47	2021-08-04
AmirAli Talasaz CHM	Chairman	46	2012-12-31
Ian Clark BRD	Director/Board Member	64	2016-11-30
Vijaya Gadde BRD	Director/Board Member	51	2020-05-31
Meghan Joyce BRD	Director/Board Member	42	2021-08-03
Myrtle Potter BRD	Director/Board Member	67	2021-10-14
Steve Krognes BRD	Director/Board Member	57	2022-06-29
Musa Tariq BRD	Director/Board Member	43	2023-03-05
Manuel Medina BRD	Director/Board Member	58	2024-07-16
Roberto Mignone BRD	Director/Board Member	54	2024-10-20

Composition of the Board of Directors

Shareholders: Guardant Health, Inc.

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.271 %	12,160,768	9.271 %	1 142 M $
BlackRock Advisors LLC 7.807 %	10,240,933	7.807 %	962 M $
T. Rowe Price International Ltd. 4.297 %	5,636,078	4.297 %	529 M $
Invesco Advisers, Inc. 4.053 %	5,315,934	4.053 %	499 M $
Baillie Gifford & Co. 3.728 %	4,890,026	3.728 %	459 M $

List of GUARDANT HEALTH, INC. shareholders

Holdings: Guardant Health, Inc.

Name	Equities	%	Valuation
LUNIT INC. 3.93%	1,150,000	3.93%	33 M $

Company details: Guardant Health, Inc.

Guardant Health, Inc.

3100 Hanover Street

94304, Palo Alto

+855 698 8887

http://www.guardanthealth.com

Diagnostic & Testing Substances

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
GUARDANT HEALTH, INC.	+2.19%	-3.29%	+105.59%	+212.10%	11.21B
BIOMÉRIEUX	-0.37%	-0.73%	-17.58%	-1.97%	12.84B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-2.24%	-3.69%	-11.82%	-14.43%	5.98B
LANTHEUS HOLDINGS, INC.	+0.35%	-0.34%	-22.41%	+1.15%	5.14B
CARIS LIFE SCIENCES, INC.	+3.97%	-0.47%	-	-	5.13B
DIASORIN S.P.A.	+0.69%	-6.39%	-32.28%	-39.97%	3.95B
ANDON HEALTH CO., LTD.	-6.06%	+12.79%	+30.36%	+22.39%	3.37B
AUTOBIO DIAGNOSTICS CO., LTD.	-0.26%	-0.46%	-17.79%	-44.69%	2.89B
10X GENOMICS, INC.	-4.55%	-12.96%	+69.14%	-63.83%	2.4B
VCANBIO CELL & GENE ENGINEERING CORP., LTD	-4.64%	-4.24%	+32.39%	+65.12%	1.96B
Average	-1.03%	-1.23%	+15.07%	+15.10%	5.49B
Weighted average by Cap.	-0.15%	-1.36%	+18.61%	+40.93%